- Home
- AIIR vs OLMA Comparison
AIIR vs OLMA Comparison
Compare AIIR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIIR | OLMA |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AIIR | OLMA |
|---|---|---|
| Price | $7.74 | $10.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $44.89 |
| AVG Volume (30 Days) | 8.8K | ★ 1.0M |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.29 | $5.36 |
| 52 Week High | $8.64 | $36.26 |
Technical Indicators
Market Signals| Indicator | AIIR | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 43.61 |
| Support Level | $6.50 | $10.71 |
| Resistance Level | $8.40 | $12.37 |
| Average True Range (ATR) | 0.67 | 0.57 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 56.84 | 40.64 |
Price Performance
Historical ComparisonAbout AIIR Air Global PLC Ordinary Shares
AIR Global PLC operates in the social inhalation products sector and has operations across multiple international markets. Its portfolio includes businesses and products related to shisha and hookah, including flavored shisha molasses, hookah and shisha e-commerce platforms, and charcoal-free shisha devices. The company also conducts product research and testing in partnership with independent laboratories to support the development of inhalation-related products and technologies.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.